BPG is committed to discovery and dissemination of knowledge
Cited by in F6Publishing
For: Dinavahi SS, Gowda R, Bazewicz CG, Battu MB, Lin JM, Chitren RJ, Pandey MK, Amin S, Robertson GP, Gowda K. Design, synthesis characterization and biological evaluation of novel multi-isoform ALDH inhibitors as potential anticancer agents. Eur J Med Chem 2020;187:111962. [PMID: 31887569 DOI: 10.1016/j.ejmech.2019.111962] [Cited by in Crossref: 18] [Cited by in F6Publishing: 18] [Article Influence: 6.0] [Reference Citation Analysis]
Number Citing Articles
1 Verma H, Narendra G, Raju B, Kumar M, Jain SK, Tung GK, Singh PK, Silakari O. 3D-QSAR and scaffold hopping based designing of benzo[d]ox-azol-2(3H)-one and 2-oxazolo[4,5-b]pyridin-2(3H)-one derivatives as selective aldehyde dehydrogenase 1A1 inhibitors: Synthesis and biological evaluation. Arch Pharm (Weinheim) 2022;:e2200108. [PMID: 35618489 DOI: 10.1002/ardp.202200108] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
2 Chowdhary S, Shalini, Arora A, Kumar V. A Mini Review on Isatin, an Anticancer Scaffold with Potential Activities against Neglected Tropical Diseases (NTDs). Pharmaceuticals 2022;15:536. [DOI: 10.3390/ph15050536] [Reference Citation Analysis]
3 Dinavahi SS, Chen YC, Gowda R, Dhanyamraju PK, Punnath K, Desai D, Berg A, Kimball SR, Amin S, Yang JM, Robertson GP. Targeting Protein Translation in Melanoma by Inhibiting EEF-2 Kinase Regulates Cholesterol Metabolism though SREBP2 to Inhibit Tumour Development. Int J Mol Sci 2022;23:3481. [PMID: 35408842 DOI: 10.3390/ijms23073481] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
4 Zanoni M, Bravaccini S, Fabbri F, Arienti C. Emerging Roles of Aldehyde Dehydrogenase Isoforms in Anti-cancer Therapy Resistance. Front Med (Lausanne) 2022;9:795762. [PMID: 35299840 DOI: 10.3389/fmed.2022.795762] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
5 Caminear MW, Harrington BS, Kamdar RD, Kruhlak MJ, Annunziata CM. Disulfiram Transcends ALDH Inhibitory Activity When Targeting Ovarian Cancer Tumor-Initiating Cells. Front Oncol 2022;12:762820. [DOI: 10.3389/fonc.2022.762820] [Cited by in Crossref: 3] [Cited by in F6Publishing: 3] [Article Influence: 3.0] [Reference Citation Analysis]
6 Malah TE, Farag H, Hemdan BA, Abdel Mageid RE, Abdelrahman MT, El-manawaty MA, Nour HF. Synthesis, in vitro antimicrobial evaluation, and molecular docking studies of new isatin-1,2,3-triazole hybrids. Journal of Molecular Structure 2022;1250:131855. [DOI: 10.1016/j.molstruc.2021.131855] [Cited by in Crossref: 4] [Cited by in F6Publishing: 5] [Article Influence: 4.0] [Reference Citation Analysis]
7 Sui L, Sanders A, Jiang WG, Ye L. Deregulated molecules and pathways in the predisposition and dissemination of breast cancer cells to bone. Computational and Structural Biotechnology Journal 2022;20:2745-58. [DOI: 10.1016/j.csbj.2022.05.051] [Cited by in Crossref: 1] [Cited by in F6Publishing: 1] [Article Influence: 1.0] [Reference Citation Analysis]
8 Pang X, Tang C, Guo R, Chen X. Non-cytochrome P450 enzymes involved in the oxidative metabolism of xenobiotics: Focus on the regulation of gene expression and enzyme activity. Pharmacol Ther 2021;:108020. [PMID: 34637840 DOI: 10.1016/j.pharmthera.2021.108020] [Cited by in Crossref: 2] [Cited by in F6Publishing: 3] [Article Influence: 2.0] [Reference Citation Analysis]
9 Ma Z, Jiang L, Li B, Liang D, Feng Y, Liu L, Jiang C. Discovery of benzimidazole derivatives as potent and selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors with glucose consumption improving activity. Bioorg Med Chem 2021;46:116352. [PMID: 34403955 DOI: 10.1016/j.bmc.2021.116352] [Cited by in Crossref: 2] [Cited by in F6Publishing: 2] [Article Influence: 2.0] [Reference Citation Analysis]
10 Guo W, Wang H, Chen P, Shen X, Zhang B, Liu J, Peng H, Xiao X. Identification and Characterization of Multiple Myeloma Stem Cell-Like Cells. Cancers (Basel) 2021;13:3523. [PMID: 34298738 DOI: 10.3390/cancers13143523] [Cited by in Crossref: 4] [Cited by in F6Publishing: 4] [Article Influence: 4.0] [Reference Citation Analysis]
11 Locquet MA, Dechaume AL, Berchard P, Abbes L, Pissaloux D, Tirode F, Ramos I, Bedoucha J, Valantin J, Karanian M, Perret R, Gille O, Blay JY, Dutour A. Aldehyde Dehydrogenase, a Therapeutic Target in Chordoma: Analysis in 3D Cellular Models. Cells 2021;10:399. [PMID: 33672032 DOI: 10.3390/cells10020399] [Cited by in Crossref: 1] [Cited by in F6Publishing: 2] [Article Influence: 1.0] [Reference Citation Analysis]
12 Raju B, Choudhary S, Narendra G, Verma H, Silakari O. Molecular modeling approaches to address drug-metabolizing enzymes (DMEs) mediated chemoresistance: a review. Drug Metab Rev 2021;53:45-75. [PMID: 33535824 DOI: 10.1080/03602532.2021.1874406] [Cited by in Crossref: 2] [Cited by in F6Publishing: 1] [Article Influence: 2.0] [Reference Citation Analysis]
13 Rashidi S, Fernández-Rubio C, Manzano-Román R, Mansouri R, Shafiei R, Ali-Hassanzadeh M, Barazesh A, Karimazar M, Hatam G, Nguewa P. Potential therapeutic targets shared between leishmaniasis and cancer. Parasitology 2021;148:655-71. [PMID: 33536086 DOI: 10.1017/S0031182021000160] [Cited by in Crossref: 10] [Cited by in F6Publishing: 10] [Article Influence: 10.0] [Reference Citation Analysis]
14 Nath R, Pathania S, Grover G, Akhtar MJ. Isatin containing heterocycles for different biological activities: Analysis of structure activity relationship. Journal of Molecular Structure 2020;1222:128900. [DOI: 10.1016/j.molstruc.2020.128900] [Cited by in Crossref: 21] [Cited by in F6Publishing: 23] [Article Influence: 10.5] [Reference Citation Analysis]
15 Li B, Yang K, Liang D, Jiang C, Ma Z. Discovery and development of selective aldehyde dehydrogenase 1A1 (ALDH1A1) inhibitors. Eur J Med Chem 2021;209:112940. [PMID: 33328099 DOI: 10.1016/j.ejmech.2020.112940] [Cited by in Crossref: 9] [Cited by in F6Publishing: 8] [Article Influence: 4.5] [Reference Citation Analysis]